David J. Horin
2016 - Array BioPharma
In 2016, David J. Horin earned a total compensation of $200K as Interim Chief Financial Officer at Array BioPharma, a 100% increase compared to previous year.
Compensation breakdown
Other | $200,000 |
---|---|
Total | $200,000 |
Horin received $200K in other compensation, accounting for 100% of the total pay in 2016.
Rankings
In 2016, David J. Horin's compensation ranked 13,398th out of 14,075 executives tracked by ExecPay. In other words, Horin earned more than 4.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,398 out of 14,075 | 5th |
Division Manufacturing | 5,239 out of 5,489 | 5th |
Major group Chemicals And Allied Products | 1,832 out of 1,895 | 3rd |
Industry group Drugs | 1,486 out of 1,538 | 3rd |
Industry Pharmaceutical Preparations | 1,137 out of 1,176 | 3rd |
Source: SEC filing on September 13, 2017.
Horin's colleagues
We found five more compensation records of executives who worked with David J. Horin at Array BioPharma in 2016.